US Microfluidics Market Size Likely to Grow at a CAGR of 11.3% By 2033

US  Microfluidics Market size was valued at USD 9.8 Billion in 2024 and is expected to reach USD 15.8 Billion by 2033, at a CAGR of 11.3% during the forecast period 2024 – 2033.

US Microfluidics Market: Overview

Microfluidics is a multidisciplinary field that focuses on the behavior, manipulation, and control of fluids at the microscale level, typically within channels or chambers with dimensions on the micrometer scale.

One prominent trend in the US microfluidics industry is the increasing integration of microfluidic devices with complementary technologies such as sensors, actuators, and data analytics. This integration enables the development of more sophisticated and versatile systems capable of performing complex analyses and tasks.

For instance, microfluidic devices coupled with biosensors allow for real-time monitoring of biochemical processes and the detection of biomolecules with high sensitivity and specificity. Furthermore, the incorporation of microfluidics into lab-on-a-chip (LOC) platforms is driving advancements in point-of-care diagnostics, personalized medicine, and drug discovery.

Another notable trend is the growing application of microfluidic technology in single-cell analysis and manipulation, facilitating insights into cellular heterogeneity, rare cell detection, and the study of complex biological processes.

Additionally, there is a rising interest in leveraging microfluidics for environmental monitoring, food safety testing, and agricultural applications due to the technology’s ability to handle small sample volumes, multiplexing capabilities, and portability. Overall, these trends indicate a continued expansion of the US microfluidics industry into diverse fields, driven by innovation and the pursuit of more efficient and effective analytical solutions.

By product, the microfluidic components segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. A prominent trend in microfluidic components is the development of customizable and modular systems, enabling researchers to easily assemble and adapt devices for specific applications.

This approach facilitates rapid prototyping, experimentation, and scalability, driving innovation and expanding the versatility of microfluidic platforms across various fields.

By technology, the lab-on-a-chip segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. A notable trend in lab-on-a-chip technology is the integration of advanced functionalities, such as on-chip sensing, automation, and sample preparation, enhancing analytical capabilities.

Additionally, there’s a focus on developing portable and user-friendly platforms for point-of-care diagnostics, driving innovation towards miniaturization and scalability in diverse applications.

Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Report Scope

CMI has comprehensively analyzed the US Microfluidics market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this US  Microfluidics industry.

The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the US Microfluidics Market:

• Illumina Inc.
• Hoffmann-La Roche Ltd.
• PerkinElmer Inc.
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Abbott
• Thermo Fisher Scientific
• Standard BioTools
• Others

The US Microfluidics Market is segmented as follows:

By Product Type

• Microfluidic-based devices
• Microfluidic Components
  • Microfluidic Chips
  • Flow & Pressure Sensors
  • Flow & Pressure Controllers
  • Microfluidic Valves
  • Micropumps
  • Microneedles
  • Other Components
• Material
  • Silicon
  • Polymer
  • Glass

By Application

• In-vitro Diagnostics
  • Clinical Diagnostics
  • Point-of-care Testing
  • Veterinary Diagnostics
• Pharmaceutical & Life Science Research and Manufacturing
  • Lab Analytics
    • Proteomics
    • Genomics
    • Cell-based Assays
    • Capillary Electrophoresis
  • Microdispensing
  • Microreaction
• Therapeutics
  • Drug delivery
  • Wearable devices

By End User

• Hospitals & Diagnostic Centers
• Academic & Research Institutes
• Pharmaceutical and biotechnology Companies